Everence Capital Management’s Medline MDLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-28,161
Closed -$1.11M – 907
2026
Q2
$1.11M Buy
28,161
+20,048
+247% +$808K 0.06% 238
2026
Q1
$361K Buy
+8,113
New +$358K 0.02% 495

Other funds holding MDLN

Everence Capital Management's MDLN Position: Q3 2026 in Review

Everence Capital Management sold out of Medline (MDLN) in Q3 2026, closing a stake of 28,161 shares — an estimated $1.11M sold.

Everence Capital Management first reported a position in MDLN in Q1 2026 and held it in 2 quarters. The position peaked at $1.11M in Q2 2026. 415 funds tracked by Wall St. Rank hold MDLN as of Q3 2026.

  • Everence Capital Management reported no remaining Medline position as of Q3 2026 after selling out during the quarter.
  • Everence Capital Management sold 28,161 Medline shares in Q3 2026, an estimated $1.11M.
  • Everence Capital Management first reported a position in Medline in Q1 2026 and held it in 2 quarters.
  • Everence Capital Management's Medline position peaked at $1.11M in Q2 2026.
  • 415 funds tracked by Wall St. Rank held Medline as of Q3 2026.

Based on Everence Capital Management's 13F filing for Q3 2026, filed 3 Nov 2026.